Product Description: Adezmapimod (SB 203580; RWJ 64809) hydrochloride is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2, respectively. Adezmapimod hydrochloride inhibits LCK, GSK3β and PKBα with IC50s of 100-500-fold higher than that for SAPK2a/p38. Adezmapimod hydrochloride does not disrupt JNK activity and is an autophagy and mitophagy activator[1].
Applications: COVID-19-immunoregulation
Formula: C21H17ClFN3OS
Citations: Acta Pharm Sin B. 5 September 2022./Anal Cell Pathol. 2022 Sep 27;2022:9358583./Biochem Pharmacol. 2024 Mar:221:116047./Cancer Res. (2022) 82 (10): 1991-2002./Cell Mol Life Sci. 2018 Jul;75(14):2627-2641./Cell Mol Life Sci. 2023 Jun 21;80(7):186./Food Chem X. 15 January 2022, 100211./Food Sci Anim Resour. Oct 12, 2022./Front Pharmacol. 2021 May 18;12:644116./Int Immunopharmacol. 2024 Apr 30:134:112143./Int J Cancer. 2018 Aug 1;143(3):645-656./Int J Mol Sci. 2023 Jul 6, 24(13), 11168./J Exp Clin Cancer Res. 2022 Sep 16;41(1):275./J Neuroinflammation. 2018 Jun 15;15(1):184./J Periodontal Res. 2021 Nov 13./JOR Spine. 2024 Apr 17;7(2):e1325./Life Sci. 2021 Dec 21;120258./New Phytol. 2024 May 13./Onco Targets Ther. 2021 Oct 22;14:5131-5144./Research Square Print. 2022 Aug./Research Square Print. September 20th, 2022./Respir Res. 2022 Jan 11;23(1):6./Viruses. 2022, 14(7), 1465./Viruses. 2022, 14(7), 1485./AAPS PharmSciTech. 2022 Mar 14;23(3):83./Acs Biomater Sci Eng. 2021 Jun 10./Acta Pharm Sin B. 2024 May 18./Acta Pharmacol Sin. 2017 Aug;38(8):1120-1128./Acta Pharmacol Sin. 2022 Feb 7./Acta Physiol (Oxf). 2018 Feb;222(2)./Acupunct Med. 2021 Jul 24;9645284211020766./Adv Sci (Weinh). 2024 Dec 30:e2413128./Adv Sci (Weinh). 2024 Oct 28:e2406979./Aging (Albany NY). 2022 Aug 5;14(15):6149-6168./Aging Cell. 2020 Oct;19(10):e13217./Aging Cell. 2022 Jun 17;e13659./Aging. 2020 Nov 20;12(23):24208-24218./Aging. 2021 May 11;13(9):12780-12799./Aging. 2021 May 6;13(10):13788-13806./Am J Physiol Cell Physiol. 2018 Aug 1;315(2):C225-C235./Am J Physiol Cell Physiol. 2022 May 18./Am J Physiol Cell Physiol. 2023 Sep 18./Am J Transl Res. 2019 Feb 15;11(2):806-818./Am J Transl Res. 2020 Feb 15;12(2):478-492./Am J Transl Res. 2020 Jul 15;12(7):3577-3595. /Ann Transl Med. 2019 Dec;7(23):758./Antioxidants (Basel). 2022 Mar 31;11(4):682./Antioxidants (Basel). 2023, Mar 30, 12(4), 838./Antioxidants (Basel). 2024 Mar 13, 13(3), 343./Antioxidants. 2021 Jun 29;10(7):1049./Antioxidants. 2021, 10(3), 443./Antiviral Res. 2022 Nov 10;105463./Apoptosis. 2021 Feb 7./Aquaculture. 2023 Dec 15, 577, 739927./Aquat Toxicol. 2018 Jun;199:116-126. /Arch Biochem Biophys. 2022: 109486./Arch Biochem Biophys. 2024 Dec 9:110255./Arch Toxicol. 2023 May 6./Artif Cell Nanomed B. 2019 Dec;47(1):3087-3093./Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):685-695./Authorea. 2022./Authorea. 2024 Jul 13./Autophagy. 2020 Aug;16(8):1413-1435./Autophagy. 2021 Nov;17(11):3592-3606./Biochem Bioph Res Co. 2020 Oct 15;531(2):187-194./Biochem Cell Biol. 2017 Feb;95(1):64-68./Biochem Pharmacol. 2024 May:223:116194./Biochim Biophys Acta Mol Basis Dis. 2022 Feb 15;1868(5):166369./Biochim Biophys Acta Mol Cell Res. 2021 Jun 17;119083./Biochim Biophys Acta Mol Cell Res. 2023 Jul 17;119540./Bioengineered. 2022 Apr;13(4):8747-8758./Biol Pharm Bull. 2022 May 31./Biol Trace Elem Res. 2023 Sep 13./Biomaterials. 2018 Aug;175:19-29./Biomaterials. 2024 Jan 1:305:122462./Biomed Pharmacother. 2018 Oct 3;108:1294-1302./Biomed Pharmacother. 2019 Dec;120:109489./Biomed Pharmacother. 2020 Jan;121:109304./Biomed Pharmacother. 2020 Mar;123:109752./Biomed Pharmacother. 2020 Sep;129:110384./Biomed Pharmacother. 2023 Jul 27;165:115231./Biomed Pharmacother. 2024 Apr 22:175:116637./Biomed Res Int. 2019 Jul 10;2019:5347804./Biomed Res. 2017; 28 (8): 3383-3386/Biomedicines. 2020 Nov 9;8(11):485./Bioorg Med Chem. 2020 Jul 1;28(13):115547/bioRxiv. 2020 Jun./bioRxiv. 2023 Aug 14./bioRxiv. 2023 Mar 24./bioRxiv. 2023 Sep 29./bioRxiv. 2024 May 2./bioRxiv. January 18, 2022./Biosci Rep. 2020 May 29;40(5):BSR20193256./BMC Cancer. 2023 Nov 14;23(1):1108./BMC Complement Altern Med. 2019 Aug 29;19(1):233./BMC Complement Med Ther. 2022 Apr 6;22(1):100./BMC Immunol. 2023 Nov 8;24(1):43./BMC Pulm Med. 2018 Nov 27;18(1):178./Br J Pharmacol. 2018 Dec;175(23):4338-4352./Br J Pharmacol. 2020 Nov;177(22):5046-5062./Brain Behav Immun. 2024 Mar 29:119:36-50./Brain Res Bull. 2021 May 25;173:162-173./Brain Sci. 2023 Jul 11, 13(7), 1058./Brain Sci. 2024 Apr 14, 14(4), 380./Can Respir J. 10 Oct 2022./Cancer Commun (Lond). 2021 Jan 1./Cancer Lett. 2017 Feb 16;393:22-32. /Carbohydr Polym. 2019 Dec 1;225:115223./Cell Commun Signal. 2021 Oct 11;19(1):103./Cell Commun Signal. 2024 Feb 12;22(1):115./Cell Commun Signal. 2024 Jun 3;22(1):307./Cell Commun Signal. 2025 Jan 13;23(1):22./Cell Commun Signal. 2025 Jan 8;23(1):14./Cell Death Differ. 2017 Mar;24(3):492-499./Cell Death Differ. 2019 Nov;26(11):2386-2399. /Cell Death Differ. 2020 Jun;27(6):1938-1951./Cell Death Dis. 2016 Jun 23;7(6):e2273. /Cell Death Dis. 2021 Jun 2;12(6):570./Cell Death Dis. 2021 Jun 7;12(6):582./Cell Death Dis. 2021 Nov 27;12(12):1113./Cell Death Dis. 2022 Jul 15;13(7):615./Cell Death Dis. 2022 Nov 23;13(11):987./Cell Death Dis. 2022 Oct 8;13(10):860./Cell Death Dis. 2019 Jul 8;10(7):520./Cell Death Dis. 2019 Mar 15;10(4):255./Cell Death Discov. 2019 Aug 5;5:125./Cell Immunol. 2024 Jun 17:401-402:104843./Cell Immunol. 2024 Oct 18:405-406:104884./Cell J. 2022 Dec 1;24(12):732-740./Cell Microbiol. 2019 Sep;21(9):e13064./Cell Mol Immunol. 2022 Nov;19(11):1263-1278./Cell Mol Immunol. 2023 Jan 5./Cell Physiol Biochem. 2018;46(5):1779-1792. /Cell Prolif. 2019 Nov;52(6):e12691./Cell Prolif. 2021 Jan;54(1):e12933./Cell Rep Med. 2024 Feb 20;5(2):101388./Cell Rep Med. 2025 Jan 16:101922./Cell Rep. 2020 Jan 14;30(2):497-509.e4. /Cell Rep. 2022 Dec 27;41(13):111891./Cell Rep. 2022 Mar 15;38(11):110520./Cell Res. 2020 Jul;30(7):574-589./Cell Signal. 2016 Feb;28(2):81-93./Cell Signal. 2019 Feb;54:17-26. /Cell Signal. 2020 Mar;67:109522./Cell Signal. 2021 Jun 2;85:110060./Cell Signal. 2024 Nov 4:111504./Cells. 2022 Feb 18;11(4):723./Chem Biodivers. 2019 Aug;16(8):e1900325./Chem Biol Interact. 2021 Sep 8;348:109634./Chem Res Toxicol. 2022 Feb 11./Chem Sci. 2018 Jan 31;9(10):2674-2689./Chemosphere. 2020 Oct;256:127038./Chin Arch Otolaryngol Head Neck Surg. 2016,23(01):49-52./Chin J Integr Med. 2024 Jun 8./Chin J Nat Med. 2023 Jan;21(1):36-46./Chin J Nat Medicines. 2020 Oct;18(10):738-748./Chin Med. 2021 Jul 19;16(1):58./China Biotechnology. 2017, 37(12): 40-48./Chinese Herbal Medicines. 1 September 2022./Clin Mol Hepatol. 2023 Feb 20./CNS Neurosci Ther. 2020 Sep;26(9):913-924./Commun Biol. 2022 Jul 22;5(1):726./Commun Biol. 2024 Jan 5;7(1):18./Commun Biol. 2024 Nov 5;7(1):1438./Connect Tissue Res. 2024 May 16:1-12./Curr Res Nutr Food Sci. 2023 Jan./Curr Res Toxicol. 2024 Oct 24:7:100199./Cytokine. 2021, 155502./Dev Comp Immunol. 2021 Oct 14;104292./Diabetes Metab Syndr Obes. 2021 Nov 12;14:4523-4534./Dis Markers. 2018 Apr 17;2018:7413027./DNA Cell Biol. 2024 Jul 24./Drug Des Devel Ther. 2024 Nov 27:18:5445-5459./Drug Dev Res. 2022 Sep 1./Ecotoxicol Environ Saf. 2020 Mar 1;190:110133./Ecotoxicol Environ Saf. 2023 Jul 13;263:115247./Elife. 2016 Apr 11;5:e14087./EMBO Mol Med. 2022 Dec 13;e16373./EMBO Rep. 2021 Jul 5;22(7):e51678./Endocrine. 2020 Apr;68(1):103-115./Environ Int. 2020 Oct;143:105949./Environ Pollut. 2020 Jan;256:113375./Environ Pollut. 2021 Jan 1;268(Pt B):115748./Environ Pollut. 2022 Oct 1;120234./Environ Toxicol. 2021 Feb;36(2):276-286./Environ Toxicol. 2022 Sep 29./Environ Toxicol. 2023 Jul 19./Environ Toxicol. 2024 Sep 13./Eur Arch Otorhinolaryngol. 2019 Mar;276(3):767-774./Eur J Integr Med. 2024 Sep 8./Eur J Pharmacol. 2021 Jun 22;174270./Eur J Pharmacol. 2021, 173982./Eur J Pharmacol. 2022 May 16;926:175034./Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):1-8. /Exp Eye Res. 2023 Jan 15./Exp Physiol. 2020 Dec 17./Exp Ther Med. 2020 Mar;19(3):1824-1834./Exp Ther Med. 2020 Mar;19(3):2243-2251./Exp Ther Med. 2021 Mar 8./Exp Ther Med. 2023 Mar 14./Exp Ther Med. October 12, 2021./Exp Ther Med. October 20, 2021./Exp Ther Med. October 28, 2021./FASEB J. 2019 Feb;33(2):2435-2450. /FASEB J. 2020 Jun;34(6):8442-8458./FASEB J. 2020 Nov;34(11):14892-14904./FEBS Open Bio. 2020 Mar;10(3):434-443./Food Biosci. 2021, 101268./Food Biosci. 7 May 2022, 101766./Food Chem Toxicol. 2020 Dec 28;148:111925./Food Chem Toxicol. 2022: 113550./Food Chem Toxicol. 2023 Apr 12;176:113784./Food Chem Toxicol. 2023 Jun 2;113870./Food Chem Toxicol. 2024 Mar 2:186:114561./Food Chem X. 2022 Apr 30;14:100321./Food Funct. 2021 Mar 9./Food Sci Anim Resour. 2024 Sep;44(5):1167-1180./Free Radic Biol Med. 2017 Nov;112:49-59./Free Radic Biol Med. 2021 Dec;177:247-259./Free Radic Biol Med. 2019 Nov 1;143:275-287./Front Biosci (Landmark Ed). 2023 Dec 1, 28(12), 325./Front Cell Dev Biol. 2021 Feb 11;9:570451./Front Cell Dev Biol. 2021 Jun 18;9:659389./Front Cell Dev Biol. 2021 Nov 5:9:741060./Front Cell Infect Microbiol. 2019 Jul 15;9:253./Front Endocrinol. 2021 Mar 12;12:629554./Front Immunol. 2017 Oct 10;8:1278./Front Immunol. 2018 Dec 7;9:2854./Front Immunol. 2018 Jun 5;9:1225. /Front Immunol. 2021 Apr 1;12:584097./Front Immunol. 2021 Jul 28;12:688294./Front Immunol. 2021 Jul 7;12:692286./Front Oncol. 2020 Sep 30;10:523577./Front Pharmacol. 2021 Apr 30;12:644886./Fundam Clin Pharmacol. 2020 Oct;34(5):591-602./Future Sci OA. 2025 Dec;11(1):2455906./Genome Biol. 2023 Feb 1;24(1):20./Glia. 2023 Mar 24./Haematologica. 2020 Jan;105(1):124-135. /Harvard Medical School LINCS LIBRARY/Hepatology. 2023 Feb 1;77(2):456-465./Hum Mol Genet. 2017 Sep 15;26(18):3553-3563./Immun Inflamm Dis. 2024 Sep;12(9):e70012./Infect Immun. 2020 Dec 14;IAI.00680-20./Inflammation. 2024 Sep 20./Int Immunopharmacol. 2019 Dec;77:105940./Int Immunopharmacol. 2019 Jul;72:252-257. /Int Immunopharmacol. 2020 Jun;83:106473./Int Immunoph
Deutsch
English
